Mann M, Mengistu A, Gaeseb J, Sagwa E, Mazibuko G, Baeten JM, Babigumira JB, Garrison LP, Stergachis A. Sentinel site active surveillance of safety of first-line antiretroviral medicines in Namibia. Pharmacoepidemiology and Drug Safety. 2016, Vol 25, Issue 9; 1052-1060. Read the full article
Archive A Stergachis
Active Surveillance versus Spontaneous Reporting for First-Line Antiretroviral Medicines in Namibia: A Cost-Utility Analysis
Mann M, Mengistu A, Gaeseb J, Sagwa E, Mazibuko G, Babigumira JB, Garrison Jr LP, Stergachis A. Active surveillance versus spontaneous reporting for first-line antiretroviral medicines in Namibia: A cost-utility analysis. Drug Safety. 2016, Vol. 39, Issue 9; 859-872. Read the full article
Sentinel Site Active Surveillance of the Safety of First-Line Antiretroviral Medicines in Windhoek Central Hospital and Katutura Intermediate Hospital
In the Republic of Namibia, the Systems for Improved Access to Pharmaceuticals and Services (SIAPS) program receives funding from the US Government to provide technical guidance for the development and implementation of innovative strategies and programs to strengthen pharmaceutical systems in support of the HIV/AIDS program. SIAPS is collaborating with USAID/Namibia to ensure the availability … Read more
Pharmacovigilance and Global HIV/AIDS
Miller V, Nwokike J, Stergachis A. Pharmacovigilance and global HIV/AIDS. Current Opinion in HIV & AIDS. 2012;7:299-304. View the abstract
Pharmacovigilance and Global HIV and AIDS
In the July 2012 issue of Current Opinion in HIV & AIDS, SIAPS has contributed to the Pharmacovigilance and global HIV/AIDS article, which focuses on the current situation in global pharmacovigilance for HIV/AIDS treatment.
